Table 4 Ovarian cancer overall survival, TTD, and TTNT estimates
Estimate | 95% CI | N of events | N remaining at risk | |
|---|---|---|---|---|
Total number of events | n/a | n/a | 3051 | 5323 |
Median OS (years) | 4.496 | (4.172- 4.862) | n/a | n/a |
1-year survival rate | 78.4% | (77.5% - 79.3%) | 1648 | 5032 |
3-year survival rate | 58.9% | (57.6% - 60.2%) | 2643 | 2120 |
5-year survival rate | 47.7% | (46.2% - 49.3%) | 2951 | 885 |
Advanced stage ovarian cancer cohort, TTD | ||||
Total number of events | n/a | n/a | 4951 | 58 |
Median TTE (years) | 0.304 | ---* | n/a | n/a |
1-year "survival" rate | 8.3% | (7.6%, 9.1%) | 4561 | 407 |
Advanced stage ovarian cancer cohort, TTNT | ||||
Total number of events | n/a | n/a | 3762 | 1247 |
Median TTE (years) | 0.46 | (0.460, 0.526) | n/a | n/a |
1-year "survival" rate | 31.9% | (30.6%, 33.3%) | 3152 | 1231 |